PainChek Management

Management criteria checks 3/4

PainChek's CEO is Philip Daffas, appointed in Sep 2016, has a tenure of 8.17 years. total yearly compensation is A$434.36K, comprised of 52.5% salary and 47.5% bonuses, including company stock and options. directly owns 1.55% of the company’s shares, worth A$683.38K. The average tenure of the management team and the board of directors is 3.7 years and 8.2 years respectively.

Key information

Philip Daffas

Chief executive officer

AU$434.4k

Total compensation

CEO salary percentage52.5%
CEO tenure8.2yrs
CEO ownership1.5%
Management average tenure3.7yrs
Board average tenure8.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Philip Daffas's remuneration changed compared to PainChek's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$434kAU$228k

-AU$8m

Mar 31 2024n/an/a

-AU$8m

Dec 31 2023n/an/a

-AU$8m

Sep 30 2023n/an/a

-AU$8m

Jun 30 2023AU$431kAU$226k

-AU$8m

Mar 31 2023n/an/a

-AU$7m

Dec 31 2022n/an/a

-AU$7m

Sep 30 2022n/an/a

-AU$6m

Jun 30 2022AU$411kAU$227k

-AU$6m

Mar 31 2022n/an/a

-AU$6m

Dec 31 2021n/an/a

-AU$7m

Sep 30 2021n/an/a

-AU$6m

Jun 30 2021AU$470kAU$232k

-AU$6m

Mar 31 2021n/an/a

-AU$5m

Dec 31 2020n/an/a

-AU$4m

Sep 30 2020n/an/a

-AU$8m

Jun 30 2020AU$4mAU$319k

-AU$12m

Mar 31 2020n/an/a

-AU$12m

Dec 31 2019n/an/a

-AU$12m

Sep 30 2019n/an/a

-AU$8m

Jun 30 2019AU$378kAU$205k

-AU$3m

Mar 31 2019n/an/a

-AU$3m

Dec 31 2018n/an/a

-AU$3m

Sep 30 2018n/an/a

-AU$4m

Jun 30 2018AU$402kAU$205k

-AU$5m

Compensation vs Market: Philip's total compensation ($USD281.47K) is about average for companies of similar size in the Australian market ($USD298.48K).

Compensation vs Earnings: Philip's compensation has increased whilst the company is unprofitable.


CEO

Philip Daffas

8.2yrs

Tenure

AU$434,361

Compensation

Mr. Philip Daffas, BSc, Dip EENG, MBA, GAICD, has been Managing Director and Director at PainChek Limited since September 30, 2016 and serves as its Chief Executive Officer. Mr. Daffas served as Vice Presi...


Leadership Team

NamePositionTenureCompensationOwnership
Philip Daffas
MD, CEO & Director8.2yrsAU$434.36k1.55%
A$ 683.4k
Iain McAdam
Chief Financial Officer3.7yrsAU$327.08k0.015%
A$ 6.7k
Andrew Hoggan
Manager & Head of Operations3.7yrsno datano data
Scott Robertson
Chief Technology Officer7.6yrsno datano data
Jeff Hughes
Chief Scientific Officerno datano datano data
David Allsopp
Head of Business Developmentno datano datano data
Natalie Climo
Company Secretaryless than a yearno datano data

3.7yrs

Average Tenure

Experienced Management: PCK's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Philip Daffas
MD, CEO & Director8.2yrsAU$434.36k1.55%
A$ 683.4k
John Murray
Non-Executive Chairman of the Board8.2yrsAU$118.75k1.04%
A$ 459.3k
Adam Davey
Non-Executive Director10.2yrsAU$59.37k0.90%
A$ 397.8k
Ross Harricks
Non-Executive Director8.2yrsAU$59.37k0.62%
A$ 275.4k
Cynthia Payne
Non-Executive Director2.7yrsAU$59.37k0.16%
A$ 71.5k
Jennifer Abbey
Member of Clinical Advisory Board6.4yrsno datano data

8.2yrs

Average Tenure

79yo

Average Age

Experienced Board: PCK's board of directors are considered experienced (8.2 years average tenure).